KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 143 filers reported holding KRYSTAL BIOTECH INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,802,000 | +710.6% | 845 | -91.8% | 1.18% | +510.9% |
Q2 2023 | $1,209,220 | +46.6% | 10,300 | 0.0% | 0.19% | +3.2% |
Q1 2023 | $824,618 | -93.7% | 10,300 | -93.8% | 0.19% | -94.1% |
Q4 2022 | $13,142,598 | +98.1% | 165,900 | +74.3% | 3.17% | +139.9% |
Q3 2022 | $6,635,000 | -77.9% | 95,200 | -83.4% | 1.32% | -37.4% |
Q3 2021 | $30,012,000 | – | 574,800 | – | 2.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |